Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2013-2020
Title: Maria Vincenza Carriero: Innovator in Cancer Research
Introduction
Maria Vincenza Carriero is a prominent inventor based in Naples, Italy. She has made significant contributions to the field of cancer research, particularly in the development of innovative peptide inhibitors that target cell migration and tumor invasion. With a total of 2 patents, her work is paving the way for new therapeutic approaches in oncology.
Latest Patents
Her latest patents include "Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells." This invention discloses retro-inverso peptides and pharmaceutical compositions that prevent key events during the metastatic process. These peptides are designed to inhibit the invasion of the extracellular matrix, formation of capillary networks, and entry into the bloodstream, making them useful in treating diseases characterized by increased cell motility and angiogenesis, such as tumors and chronic inflammation. Another notable patent involves peptides with pharmacological activity for treating disorders associated with altered cell migration, particularly cancer. These peptides, represented by the general formula L-X-X-X-X, are effective in the treatment and prevention of tumors.
Career Highlights
Maria has worked with esteemed organizations such as the Istituto Nazionale Tumori Irccs “Fondazione G. Pascale” and Pharmaphelix S.r.l. Her research has been instrumental in advancing the understanding of cancer biology and developing new therapeutic strategies.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues, including Gennaro Ciliberto and Katia Bifulco. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Maria Vincenza Carriero stands out as a leading inventor in the field of cancer research. Her groundbreaking work on peptide inhibitors is set to make a significant impact on the treatment of cancer and related diseases.